<VariationArchive VariationID="1435168" VariationName="NM_001080.3(ALDH5A1):c.660_666del (p.Ala221fs)" VariationType="Deletion" Accession="VCV001435168" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1422143" VariationID="1435168">
      <GeneList>
        <Gene Symbol="ALDH5A1" FullName="aldehyde dehydrogenase 5 family member A1" GeneID="7915" HGNC_ID="HGNC:408" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="24494969" stop="24537207" display_start="24494969" display_stop="24537207" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="24495196" stop="24537434" display_start="24495196" display_stop="24537434" Strand="+" />
          </Location>
          <OMIM>610045</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001080.3(ALDH5A1):c.660_666del (p.Ala221fs)</Name>
      <CanonicalSPDI>NC_000006.12:24504915:GGCAGCCGGC:GGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="24504916" stop="24504922" display_start="24504916" display_stop="24504922" variantLength="7" positionVCF="24504915" referenceAlleleVCF="TGGCAGCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="24505144" stop="24505150" display_start="24505144" display_stop="24505150" variantLength="7" positionVCF="24505143" referenceAlleleVCF="TGGCAGCC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A221fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.24505147_24505153del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.24505147_24505153del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.24504919_24504925del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.24504919_24504925del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008161.1" sequenceAccession="NG_008161" sequenceVersion="1" change="g.14951_14957del">
            <Expression>NG_008161.1:g.14951_14957del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001080.3" sequenceAccession="NM_001080" sequenceVersion="3" change="c.660_666del" MANESelect="true">
            <Expression>NM_001080.3:c.660_666del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001071.1" sequenceAccession="NP_001071" sequenceVersion="1" change="p.Ala221fs">
            <Expression>NP_001071.1:p.Ala221fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368954.1" sequenceAccession="NM_001368954" sequenceVersion="1" change="c.660_666del">
            <Expression>NM_001368954.1:c.660_666del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355883.1" sequenceAccession="NP_001355883" sequenceVersion="1" change="p.Ala221fs">
            <Expression>NP_001355883.1:p.Ala221fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170740.1" sequenceAccession="NM_170740" sequenceVersion="1" change="c.660_666del">
            <Expression>NM_170740.1:c.660_666del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733936.1" sequenceAccession="NP_733936" sequenceVersion="1" change="p.Ala221fs">
            <Expression>NP_733936.1:p.Ala221fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2127382929" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001080.3(ALDH5A1):c.660_666del (p.Ala221fs) AND Succinate-semialdehyde dehydrogenase deficiency" Accession="RCV001984815" Version="3">
        <ClassifiedConditionList TraitSetID="369">
          <ClassifiedCondition DB="MedGen" ID="C0268631">Succinate-semialdehyde dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14635103</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="369" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4471" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">4-hydroxybutyric aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gamma-hydroxybutyricaciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Succinate-semialdehyde dehydrogenase deficiency</ElementValue>
                <XRef ID="Succinic+semialdehyde+dehydrogenase+deficiency/6917" DB="Genetic Alliance" />
                <XRef ID="49748000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SSADHD</ElementValue>
                <XRef Type="MIM" ID="271980" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7695" />
                <XRef ID="7695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Succinic semialdehyde dehydrogenase (SSADH) deficiency is characterized by infantile-onset hypotonia, developmental delay, cognitive impairment, expressive language deficit, and mild ataxia. Epilepsy is present in about half of affected individuals and is more common in adults. Hyperkinetic behavior, aggression, self-injurious behaviors, hallucinations, and sleep disturbances have been reported in nearly half of all affected individuals, more commonly in those who are older. Basal ganglia signs including choreoathetosis, dystonia, and myoclonus have been reported in a few individuals with earlier-onset, more severe disease. Involvement beyond the central nervous system has not been described. Individuals with SSADH deficiency typically have 4-hydroxybutyric aciduria present on urine organic acid analysis. Head MRI reveals T2 hyperintensities in multiple regions, involving the globus pallidi, cerebellar dentate nuclei, subthalamic nuclei, subcortical white matter, and brain stem, as well as cerebral and sometimes cerebellar atrophy. EEG findings include background slowing and spike discharges that are usually generalized.</Attribute>
                <XRef ID="NBK1195" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301374</ID>
                <ID Source="BookShelf">NBK1195</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="22" DB="Orphanet" />
              <XRef ID="C0268631" DB="MedGen" />
              <XRef ID="MONDO:0010083" DB="MONDO" />
              <XRef Type="MIM" ID="271980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4234500" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14445588|MedGen:C0268631" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002207530" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14635103</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala221Valfs*5) in the ALDH5A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDH5A1 are known to be pathogenic (PMID: 14635103). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ALDH5A1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH5A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.24505144_24505150del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268631" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4234500" TraitType="Disease" MappingType="XRef" MappingValue="C0268631" MappingRef="MedGen">
        <MedGen CUI="C0268631" Name="Succinate-semialdehyde dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

